S-1/AS-1/A
Jun 26, 2026Amended0001493152-26-030330
All companies
Trade Akari Therapeutics Plc
AK
Akari Therapeutics Plc
AKTXPublic
PublicUnited States(NASDAQ-CM)Best valuation $16.89M1 market
Public listing
Listed· NASDAQ-CM· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, nasdaq
IPO Calendar · NASDAQ-CMIPO
AKTXPrice
$10.73
24h
+12.71%
Valuation
$16.89M
24h volume
$996.19K
Type
IPO
Trade Akari Therapeutics PlcNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 2h ago
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2023 · CIK 0001541157.
Revenue · -39.46% YoY
$367.88K
Net income
-$17.3M
Gross margin
—
Cash
$0
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | $367.88K | $607.68K | — |
| Operating income | -$17.28M | -$21.64M | -$16.81M | -$11.85M | -$17.21M |
| Net income | -$17.3M | -$19.8M | -$10.01M | -$13.09M | -$17.42M |
| R&D expense | $2.82M | $6.98M | $5.45M | $3.92M | $9.13M |
| Cash & equivalents | $0 | $0 | $3.85M | $13.25M | $9.36M |
| Total assets | $47.89M | $50.56M | $4.36M | $13.83M | $11.65M |
| Total liabilities | $19.56M | $28.33M | $4.58M | $12.04M | $6.09M |
| Shareholders' equity | $28.33M | $22.23M | -$229K | $1.79M | $5.56M |
SEC IPO filings
AmendedEDGAR filings resolved from AKTX / CIK 0001541157.
RWRW
May 21, 2026Withdrawn0001493152-26-024741
S-1S-1
May 8, 2026Filed0001493152-26-022019
Apr 15, 2026Effective9999999995-26-001192
Apr 2, 2026Confidential draft0001493152-26-014977
Jan 29, 2026Effective9999999995-26-000356
UPLOADfilename1.pdf
Jan 27, 2026SEC correspondence0000000000-26-000815
CORRESPfilename1.htm
Jan 27, 2026SEC correspondence0001493152-26-003763
S-1S-1
Jan 23, 2026Filed0001493152-26-003458
424B3424B3
Dec 5, 2025Final prospectus0001493152-25-026387
Dec 2, 2025Effective9999999995-25-003483
CORRESPfilename1.htm
Dec 1, 2025SEC correspondence0001493152-25-025537
Akari Therapeutics Plc IPO — frequently asked questions
- When did Akari Therapeutics Plc go public?
- Akari Therapeutics Plc has already gone public and now trades publicly on NASDAQ-CM under the ticker AKTX.
- Can I buy Akari Therapeutics Plc stock?
- Yes — Akari Therapeutics Plc is publicly traded on NASDAQ-CM as AKTX. You can follow its live price, valuation and post-IPO performance above.
- What is Akari Therapeutics Plc's valuation?
- Akari Therapeutics Plc's most recent valuation tracked here is $16.89M, derived from live market prices.